Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Lexeo Therapeutics Inc (NASDAQ: LXEO) was $4.12 for the day, down -1.44% from the previous closing price of $4.18. In other words, the price has decreased by -$1.44 from its previous closing price. On the day, 0.96 million shares were traded. LXEO stock price reached its highest trading level at $4.2 during the session, while it also had its lowest trading level at $4.01.
Ratios:
Our analysis of LXEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.42 and its Current Ratio is at 3.42. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on June 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $28.
On June 06, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $22.
On November 28, 2023, Stifel started tracking the stock assigning a Buy rating and target price of $20.Stifel initiated its Buy rating on November 28, 2023, with a $20 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 ’25 when Townsend Richard Nolan sold 1,074 shares for $2.77 per share. The transaction valued at 2,979 led to the insider holds 221,173 shares of the business.
Adler Eric sold 585 shares of LXEO for $1,623 on May 16 ’25. The Chief Medical Officer now owns 67,681 shares after completing the transaction at $2.77 per share. On May 16 ’25, another insider, Robertson Jenny, who serves as the Chief Legal Officer of the company, sold 521 shares for $2.77 each. As a result, the insider received 1,445 and left with 63,098 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LXEO now has a Market Capitalization of 136750624 and an Enterprise Value of 46302716.
Stock Price History:
The Beta on a monthly basis for LXEO is 1.16, which has changed by -0.7360666 over the last 52 weeks, in comparison to a change of 0.12748289 over the same period for the S&P500. Over the past 52 weeks, LXEO has reached a high of $19.50, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is 18.40%, while the 200-Day Moving Average is calculated to be -26.04%.
Shares Statistics:
LXEO traded an average of 905.20K shares per day over the past three months and 593100 shares per day over the past ten days. A total of 33.19M shares are outstanding, with a floating share count of 25.03M. Insiders hold about 24.61% of the company’s shares, while institutions hold 90.35% stake in the company. Shares short for LXEO as of 1749772800 were 4783707 with a Short Ratio of 5.28, compared to 1747267200 on 3114846. Therefore, it implies a Short% of Shares Outstanding of 4783707 and a Short% of Float of 16.81.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
